Source: International Congress 2018 – Improving the quality of life of patients with bronchiectasis
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
J. Hernandez Borge (Badajoz, Spain), M. Benitez-Cano Gamonoso (Badajoz, Spain), M. Antona Rodriguez (Badajoz, Spain), M. Gomez Vizcaino (Badajoz, Spain), P. IñIgo Naranjo (Badajoz, Spain), P. Cordero Montero (Badajoz, Spain), A. Sanz Cabrera (Badajoz, Spain), J. Gutierrez Lara (Badajoz, Spain), L. Sierra Murillo (Badajoz, Spain), K. El Boutaibi Faiz (Badajoz, Spain), F. Marquez Perez (Badajoz, Spain). Factors related to microbiological isolates in patients with Non Cystic-Fibrosis Bronquiectasis (Non-CFBQ). 2666

Member's Comments

No comment yet.

Related content which might interest you: Factors affecting treatment success in community acquired pneumonia (CAP) Source: Annual Congress 2013 –Pneumonia and sepsis Year: 2013 Clinical characteristics and prognostic factors of patients with Stenotrophomonas maltophilia pneumonia: 10 years experience of single center Source: International Congress 2019 – Airway infection in COPD Year: 2019 Change in the susceptibility pattern of Streptococcus pneumoniae (SP) and risk factors (RF) for antibiotic resistance (AR) in patients with community-acquired pneumonia (CAP) Source: Eur Respir J 2003; 22: Suppl. 45, 546s Year: 2003 Clinical outcomes of patients with HAP/VAP due to PVL(+) vs. PVL(-) MRSA: Results from the IMPACT-HAP study Source: Annual Congress 2010 - Healthcare-associated pneumonia: ventilator-associated pneumonia and pneumonia in hospitalised patients Year: 2010 Epidemiological and clinical features of non tuberculous mycobacteria infection (NTM) in a five-year single centre experience Source: International Congress 2016 – Clinical and microbiological aspects of bronchiectasis and non-tuberculous mycobacterium (NTM) infections Year: 2016 Dynamic of resistance of streptococcus pneumoniae strains from patients with CAP in theritary tertyary hospital: 10 years prospective study Source: International Congress 2016 – Microbiological issues and translational research in respiratory infections Year: 2016 Clinical and microbiological characteristics of Pseudomonas aeruginosa isolates from patients with COPD Source: Eur Respir J 2005; 26: Suppl. 49, 58s Year: 2005 High carbapenem resistance in gram negative bacterial isolates: An outcome study Source: Annual Congress 2013 –Infection, sepsis and outcomes in ICU Year: 2013 Comparison of severity scores to predict outcomes in elderly patients with community acquired pneumonia Source: International Congress 2015 – CAP: prognostic factors in frail patients Year: 2015 Clinical features, outcome and factors associated with mortality in patients with Nocardia pneumonia Source: Annual Congress 2012 - Viral infections and rare respiratory infections Year: 2012 Clinical cure rates in patients treated with azithromycin (AZ) for lower respiratory infections (LRTI) caused by AZ-susceptible (AZ-S) and AZ-resistant (AZ-R) organisms: Analysis of phase 3 clinical trials Source: International Congress 2014 – Respiratory symptoms in primary care populations Year: 2014 Clinical, radiological and bacteriological features in geriatric tuberculosis (TB) patients (pts) - initial treatment and outcome Source: Eur Respir J 2002; 20: Suppl. 38, 363s Year: 2002 Clinical impact of a prediction score for drug-resistance in community-onset pneumonia Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment Year: 2016 Factors associated with treatment outcome in 64 HIV negative patients with multidrug resistant tuberculosis Source: Annual Congress 2011 - Risk factors and treatment outcomes in multidrug- and extensively drug-resistant tuberculosis Year: 2011 Laboratory findings, physical and clinical features of mycoplasma pneumoniae infections. Analysis of 21 cases Source: Eur Respir J 2004; 24: Suppl. 48, 716s Year: 2004 Differences in prognostic factors and outcome in community-acquired pneumonias (CAP) caused by viral pathogens (VP) or streptococcus pneumoniae (SP) Source: Eur Respir J 2001; 18: Suppl. 33, 542s Year: 2001 Clinical factors associated with delayed diagnosis in hospitalized community-acquired pneumonia (CAP). Impact on the outcome Source: Annual Congress 2010 - Risk factors and outcomes in community-acquired pneumonia Year: 2010 Antibiotic resistance genotype trend and association with host clinical characteristics in respiratory isolates of streptococcus pneumoniae Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options Year: 2014 Factors affecting tuberculosis treatment: the beliefs of patients Source: Eur Respir J 2005; 26: Suppl. 49, 649s Year: 2005 Clinical characteristics of 11 cases of pulmonary abscess in children Source: Annual Congress 2013 –Interesting cases of respiratory infections Year: 2013